Mina Mirzaian

Elevated globotriaosylsphingosine is a hallmark of Fabry disease

Johannes M. F. G. Aerts, J.E.M. Groener, Sijmen Kuiper et al. · Proceedings of the National Academy of Sciences · 2008 · 715 citations · Full text

Metabolic Syndrome, Fabry Disease, Lipid Storage +15

Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases

María Pía Ferraz, André R. A. Marques, Monique D. Appelman et al. · FEBS Letters · 2016 · 141 citations · Full text

Acid Ceramidase, Gaucher Disease, Biochemistry +13

Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome

Saskia M. Rombach, Johannes M. F. G. Aerts, Ben J. H. M. Poorthuis et al. · PLoS ONE · 2012 · 129 citations · Full text

Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring

Mohan Ghorasaini, Yassene Mohammed, Jerzy Adamski et al. · Analytical Chemistry · 2021 · 93 citations · Full text

Quantification of Globotriaosylsphingosine in Plasma and Urine of Fabry Patients by Stable Isotope Ultraperformance Liquid Chromatography–Tandem Mass Spectrometry

Henrik Gold, Mina Mirzaian, Nick Dekker et al. · Clinical Chemistry · 2012 · 90 citations · Full text